VVA
CNTA

Vida Ventures Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Vida Ventures Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,931,818
Closed -$65.9M – 4
2024
Q4 		$65.9M Hold
3,931,818
– – 45.01% 1
2024
Q3 		$62.9M Hold
3,931,818
– – 45.36% 1
2024
Q2 		$35.5M Hold
3,931,818
– – 38.83% 1
2024
Q1 		$44.4M Hold
3,931,818
– – 24.68% 2
2023
Q4 		$31.3M Hold
3,931,818
– – 37.26% 1
2023
Q3 		$25.4M Hold
3,931,818
– – 39.38% 1
2023
Q2 		$24.3M Hold
3,931,818
– – 31.78% 2
2023
Q1 		$15.1M Hold
3,931,818
– – 20.71% 2
2022
Q4 		$12.2M Hold
3,931,818
– – 16.38% 3
2022
Q3 		$15.8M Hold
3,931,818
– – 14.18% 4
2022
Q2 		$19.1M Hold
3,931,818
– – 16.18% 4
2022
Q1 		$35.3M Hold
3,931,818
– – 20.51% 1
2021
Q4 		$44.3M Hold
3,931,818
– – 16.56% 3
2021
Q3 		$65.7M Hold
3,931,818
– – 18.81% 1
2021
Q2 		$87.3M Buy
+3,931,818
New +$92.4M 21.9% 1

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return